Literature DB >> 12118909

Correlation between diastolic impairment and lipid metabolism in mild-to-moderate hypertensive postmenopausal women.

Pasquale Palmiero1, Maria Maiello, Andrea Passantino, Ettore Antoncecchi, Carlo Deveredicis, Antonietta DeFinis, Vittoria Ostuni, Elio Romano, Pietro Mengoli, Divina Caira.   

Abstract

BACKGROUND: Many cardiovascular risk factors are found in hypertensive patients. The aim of this study was to evaluate the correlation between cardiac abnormalities (ie, diastolic and left ventricular hypertrophy) with other cardiovascular risk factors in postmenopausal women with hypertension.
METHODS: A total of 200 consecutive postmenopausal women (mean age 47.5+/-4 years) with mild-to-moderate hypertension that had never been treated were studied. Mean systolic pressure was 163+/-15 mm Hg and mean diastolic pressure 97+/-75 mm Hg. All subjects underwent M-mode two-dimensional echocardiography and cardiac Doppler. The following measurements were made: peak velocity of early left ventricular filling (E); peak velocity of late ventricular filling (A), and the ratio between early and late flow velocity peaks (E/A). The E/A ratio was then normalized for heart rate (E/Ac). Left ventricular mass index normalized for body surface was also measured. In each patient, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and plasma triglycerides were measured. We evaluated the correlation of E/Ac and left ventricular mass index (LVMI) with the following variables: total cholesterol, HDL, LDL, triglyceridemia, smoking status, systolic and diastolic blood pressure, and body mass index.
RESULTS: A significant negative correlation with total cholesterol (r = -0.15, P < .05) and LDL (r = -0.20; P = .005), as well as a significant positive correlation with HDL (r = 0.20, P < .01) were found. No other variable was significantly correlated with E/A. There was no correlation between LVMI and any variable analyzed.
CONCLUSION: In postmenopausal women with mild-to-moderate hypertension, high total cholesterol levels and low HDL levels are associated with impaired diastolic function.

Entities:  

Mesh:

Year:  2002        PMID: 12118909     DOI: 10.1016/s0895-7061(02)02934-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect.

Authors:  Dallit Mannheim; Joerg Herrmann; Piero O Bonetti; Ronit Lavi; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2011-02-24       Impact factor: 5.162

2.  Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

3.  Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension.

Authors:  Dong-Mei Miao; Ping Ye; Wen-Kai Xiao; Peng Gao; Jin-Yao Zhang; Hong-Mei Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-14       Impact factor: 3.738

4.  Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction.

Authors:  Jiyun Park; Mira Kang; Jiyeon Ahn; Min Young Kim; Min Sun Choi; You-Bin Lee; Gyuri Kim; Kyu Yeon Hur; Jae Hyeon Kim; Jeong Hoon Yang; Sang-Man Jin
Journal:  Diabetes Metab J       Date:  2021-11-22       Impact factor: 5.376

5.  Determinants of Left Atrial Compliance in the Metabolic Syndrome: Insights from the "Linosa Study".

Authors:  Paolo Barbier; Edvige Palazzo Adriano; Daniela Lucini; Massimo Pagani; Gaspare Cusumano; Beatrice De Maria; Laura Adelaide Dalla Vecchia
Journal:  J Pers Med       Date:  2022-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.